Материалов:
1 005 012

Репозиториев:
30

Авторов:
596 024

По вашему запросу найдено документов: 25973

Страница 4 из 2598

Маркеры гемодинамического стресса и развитие неблагоприятного ремоделирования левого желудочка у пациентов с инфарктом миокарда с подъемом сегмента ST
Рябова, Тамара Ростиславовна, Гусакова, Анна Михайловна, Суслова, Татьяна Евгеньевна, Рябов, Вячеслав Валерьевич, Карпов, Ростислав Сергеевич, Керчева, Мария Анатольевна
elevation myocardial infarction
THE PROGNOSTING VALUE OF COMBING NEW BIOMARKERS FOR REMOTE CARDIOVASCULAR ENDPOINTS RISK STRATIFICATION IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION
ZAGIDULLIN, N.SH., HAMITOVA, A., LAKMAN, I., KRIONI, I., GAREEVA, D., ZULKARNEEV, R., TULBAEV, E.
The biomarkes NT-proBNP, ST2 and Pentraxin-3 (Ptx-3) have emerged as potential powerful tools
Quantifying the area-at-risk of myocardial infarction in-vivo using arterial spin labeling cardiac magnetic resonance
Dongworth R., Campbell-Washburn A., Cabrera-Fuentes H., Bulluck H., Roberts T., Price A., Hernández-Reséndiz S., Ordidge R., Thomas D., Yellon D., Lythgoe M., Hausenloy D.
quantify the area-at-risk (AAR) following acute myocardial infarction (AMI), and has been used to assess
Results of International, Double-Blind, Randomized, Placebo-Controlled, Phase IIa Study of Interleukin-1 Blockade with RPH-104 (Goflikicept) in Patients with ST-Segment-Elevation Myocardial Infarction (STEMI)
Abbate A., Van Tassell B., Bogin V., Markley R., Pevzner D.V., Cremer P.C., Meray I., Privalov D.V., Taylor A., Grishin S.A., Egorova A.N., Ponomar E.G., Lavrovsky Y., Samsonov M.Y., Pisaryuk A., Babaeva L., Zyuryaev I., Kalimulin D., Lapin O., Mekhriakov S., Popov N., Kalashnikov I., Duhanina E., Osmanova S., Kornilov E., Zubova E., Safarian V., Selezneva N., Savelieva E., Privalova O., Shogenov Z., Novosadov V., Agirov M., Nilk R., Fedash A., Yurkovskiy A., Kotova A., Staroverov I., Mayorov V., Lonchakova O., Rozanov D., Yakushin S., Seleznev S., Pravkina E., Pereverzeva K., Ivanova G., Turlington J.S., Thomas G., Talasaz A.H., Golino M., Buono M.G.D., Marawan A., Damonte J.I.
of Interleukin-1 Blockade with RPH-104 (Goflikicept) in Patients with ST-Segment-Elevation Myocardial Infarction
Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial
Iglesias J.F., Roffi M., Muller O., Eeckhout E., Heg D., Losdat S., Zwahlen M., Kurz D.J., Moarof I., Weilenmann D., Kaiser C., Tapponnier M., Stortecky S., Valgimigli M., Windecker S., Pilgrim T., Odutayo A., Jüni P.
durable polymer everolimus-eluting stents in patients with acute ST-segment elevation myocardial
Contrast-induced acute kidney injury after primary percutaneous coronary interventions: Prevalence, predictive factors, and outcomes
Kobalava Zh.D., Villevalde S.V., Gaskina A.A., Mayskov V.V., Moiseev V.S.
-induced acute kidney injury (CIAKI) in patients with ST-segment elevation acute coronary syndrome (STSEACS), who
TYPE 2 MYOCARDIAL INFARCTION: CLINICAL AND DEMOGRAPHIC FEATURES, LABORATORY AND INSTRUMENTAL ASSOCIATIONS
Hoang H.T., Kitbalyan A.A., Lazarev P.V., Maiskov V.V., Shkolinikova E.E., Meray I.A.
present without ST segment elevation (p = 0.001) and have lower troponin values (p = 0.001). They also had
Fortelyzin® in comparison with metalyse® for ST-elevated myocardial infarction: One-year results and clinical outcomes of a multicenter randomized study FRIDOM1
Markov V.A., Duplyakov D.V., Konstantinov S.L., Klein G.V., Aksentev S.B., Platonov D.Y., Vyshlov E.V., Ponomarev E.A., Rabinovich R.M., Makarov E.L., Kulibaba E.V., Yunevich D.S., Kritskaia O.V., Baranov E.A., Talibov O.B., Gerasimets E.A.
of the Russian Federation in the period 2014-2016. The study included 382 patients with acute ST-elevated
ОСОБЕННОСТИ РЕМОДЕЛИРОВАНИЯ ЛЕВОГО ЖЕЛУДОЧКА У БОЛЬНЫХ ОСТРЫМ ИНФАРКТОМ МИОКАРДА С ПОДЪЕМОМ И БЕЗ ПОДЪЕМА СЕГМЕНТА ST
Закирова, Н.Э., Казиева, З.А., Закирова, А.Н., Zakirova, N.E., Kazieva, Z.A., Zakirova, A.N.
(STEMI) and non-ST segment elevation (non-STEMI) myocardial infarction (MI). Materials and methods
TCTAP C-025 EMBOLIC MYOCARDIAL INFARCTION CAUSED BY LEFT ATRIUM EMBOLI FROM ATRIAL FIBRILLATION
Zagitov, I.G., Plechev, V.V., Nikolaeva, I.E., Buzaev, I.V.
to catheterization ECG revealed ST elevation at II, III, AVF leads. Cardiac troponins were positive. INR 1

Страница 4 из 2598

Фасеты

Новости проекта

Новости

Партнеры

КФУ
ТГУ
Elpub
СФУ
Webpublishers

Индексация

BASE
WorldCat
OpenAIRE
EDS
core